[New promising treatments of Ebola virus disease are underway]

Area of Science:

• Epidemiology
• Infectious Diseases
• Public Health

Background:

• The recent Ebola epidemic was the largest recorded, presenting unprecedented public health challenges.
• Despite the scale, no specific Ebola virus treatments emerged as major breakthroughs.

Purpose of the Study:

• To review lessons learned from the largest Ebola epidemic.
• To assess the status of Ebola treatments and vaccines.
• To identify emerging paradigms in epidemic response.

Main Methods:

• Analysis of clinical trial data and outcomes from the Ebola epidemic.
• Review of ongoing vaccine and drug development pipelines.
• Evaluation of the impact of supportive care.

Main Results:

• Intensive supportive care demonstrated significant value in managing Ebola cases.
• Clinical trials for new Ebola products were initiated late, limiting patient enrollment.
• One vaccine candidate showed 100% efficacy in ongoing trials.

Conclusions:

• The Ebola epidemic underscored the critical role of supportive care.
• There is a need for a paradigm shift towards accelerated drug and vaccine testing during epidemics.
• Future responses must prioritize early and efficient clinical evaluations.